Mercer Global Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Mercer Global Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Sell	9,704 -9,782	-50%	-$2.11M	﹤0.01%	1225
2026 Q1	$3.91M	Buy	+19,486	New	+$4.03M	0.01%	870
2024 Q1	–	Sell	-1,356	Closed	-$214K	–	2064
2023 Q4	$214K	Buy	+1,356	New	+$195K	﹤0.01%	1799

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Mercer Global Advisors's FBT Position: Q2 2026 in Review

Mercer Global Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 50% in Q2 2026, selling an estimated $2.11M and leaving 9,704 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Mercer Global Advisors first reported a position in FBT in Q4 2023 and has held it in 3 quarters since. The position peaked at $3.91M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Mercer Global Advisors held 9,704 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.41M as of Q2 2026.
Mercer Global Advisors sold 9,782 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $2.11M.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1225 holding.
Mercer Global Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 3 quarters since.
Mercer Global Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.91M in Q1 2026.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.